Biotechnology Assets SA
MAD:BST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biotechnology Assets SA
MAD:BST
|
ES |
|
D
|
DSM-Firmenich AG
AEX:DSFIR
|
CH |
|
Zignago Vetro SpA
F:ZVB
|
IT |
|
V
|
Vunani Ltd
JSE:VUN
|
ZA |
|
A
|
Ardelyx Inc
F:41X
|
US |
|
Tegna Inc
NYSE:TGNA
|
US |
|
O
|
Obayashi Corp
F:OBA
|
JP |
|
Fomento de Construcciones y Contratas SA
MAD:FCC
|
ES |
|
Taiwan Environment Scientific Co Ltd
TWSE:8476
|
TW |
|
Denison Mines Corp
TSX:DML
|
CA |
|
HS Holdings Co Ltd
TSE:8699
|
JP |
|
V
|
Value Grupo Financiero SAB de CV
BMV:VALUEGFO
|
MX |
Bankruptcy Probability
Biotechnology Assets SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biotechnology Assets SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ES |
|
Biotechnology Assets SA
MAD:BST
|
14.5m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
459.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
87.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biotechnology Assets SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biotechnology Assets SA has total debt of 1m EUR. This includes both short-term (0 EUR) and long-term (1m EUR) debt.
You can find a full breakdown on its Balance Sheet.
